首页>
外国专利>
AGENT FOR TREATMENT OF HUMAN BODY CONDITIONS ASSOCIATED WITH A DECREASE IN THE LEVEL OF ANG GENE EXPRESSION AND/OR A REDUCTION IN THE AMOUNT AND/OR ACTIVITY OF AN ANGIOGENIN PROTEIN BASED ON GENE THERAPY, A METHOD OF PRODUCTION AND USE
AGENT FOR TREATMENT OF HUMAN BODY CONDITIONS ASSOCIATED WITH A DECREASE IN THE LEVEL OF ANG GENE EXPRESSION AND/OR A REDUCTION IN THE AMOUNT AND/OR ACTIVITY OF AN ANGIOGENIN PROTEIN BASED ON GENE THERAPY, A METHOD OF PRODUCTION AND USE
FIELD: biochemistry.;SUBSTANCE: invention relates to biochemistry, namely to agent for treating conditions of the human body, ANG gene expression and/or reduction in the amount and/or activity of the angiogenin protein based on the gene therapeutic substance with the ANG gene, which is a genetic construct based on a vector plasmid comprising the cDNA of the ANG gene, with the coding sequence of the angiogenin protein, with deletions of 5' and 3'-non-translated regions, and regulatory elements that increase the expression of the ANG gene in eukaryotic cells and in cells of human organs and tissues selected from fibroblasts, epithelial cells of the cornea of the eye, skin, mucous membrane of the oral cavity or muscle tissue, in combination with a transport molecule or without it, when this agent is administered to human organs and tissues. Invention also relates to process for preparation of the above-mentioned agent and a method for its use.;EFFECT: invention provides highly effective treatment of human body conditions associated with a decrease in the expression level of the ANG gene and/or reduction in the amount and/or activity of the angiogenin protein.;5 cl, 20 dwg, 18 ex
展开▼
机译:基于ANG的基因治疗物质技术领域本发明涉及生物化学,即涉及用于治疗人体状况,ANG基因表达和/或降低血管生成素蛋白的量和/或活性的试剂。基因,其是基于载体质粒的遗传构建体,该载体质粒包含ANG基因的cDNA,具有血管生成素蛋白的编码序列,5'和3'-非翻译区的缺失以及增加表达的调控元件真核细胞以及选自成纤维细胞,眼角膜上皮细胞,皮肤,口腔粘膜或肌肉组织的人类器官和组织的细胞中ANG基因与运输分子的结合或不结合,当这种药剂被施用于人体器官和组织时。本发明还涉及上述试剂的制备方法及其使用方法。效果:本发明提供了与ANG基因表达水平降低和/或ANG基因表达降低相关的人体疾病的高效治疗。血管生成素蛋白的量和/或活性; 5 cl,20 dwg,18 ex
展开▼